Associate Fellow of Industrial Health [AFIH]
Accepted entrance exams
Fees
Fees at SRM Institute of Science and Technology (SRMIST) for the Bachelor of Technology [B.Tech] in Biotechnology program range between 250,000 to 285,000 INR per annum. An initial registration fee of 10,000 INR is required at the time of admission, which is non-refundable. Examination fees per semester typically range from 1,500 to 3,000 INR. The total tuition fees over the duration of the four-year program could accumulate to 10- 18 lakh INR, depending on various factors such as admission through management quota or merit-based entrance exams like the SRMJEEE.
Scholarships are available and may cover up to 75% of the fees, contingent on performance in the SRMJEEE exam or maintaining a specified CGPA. Additionally, hostel fees can range from 18,000 to 250,000 INR annually, depending on facilities chosen. Various scholarships, including merit-based and specific quota scholarships, are offered to reduce the financial burden.
About Associate Fellow of Industrial Health [AFIH]
AFIH Industrial Health at SRM University Chennai is a 3 months, Full Time Degree program offered On Campus. It offers a limited number of 25 seats.
- The total fees for the AFIH Industrial Health program at SRM University Chennai is ₹ 1 Lakh.
According to an external review site Medical Ranking 2025, SRM University Chennai ranks 29 out of 522 colleges in India with an overall score of 1926.58 out of 2000 and a placement score of 0 out of 1000. NIRF Medical ranking 2025, ranks SRM University Chennai at 18 out of 50 in India.
Find detailed SRM University Chennai AFIH Industrial Health fees, eligibility, admission dates, cutoff and ranking below.
SRM University Chennai AFIH Industrial Health fees 2025 is ₹ 1 Lakh for the entire course duration.- SRM University Chennai Hostel Fee is ₹ 1.18 Lakhs.
According to an external review site Ranking 2025, SRM University Chennai ranks 29 out of 522 colleges in India and 5 in state Tamil Nadu for its AFIH Industrial Health program.
- 18 out of 50 under NIRF Medical Ranking 2025.
- 6 out of 57 under IIRF Medical Ranking 2025.
- 9 out of 23 under Outlook Medical Ranking 2021.